Sugars boost exhausted tumor-infiltrating lymphocytes by counteracting immunosuppressive activities of galectins

Tekijä Gordon-Alonso, Monica, Demotte, Nathalie, van der Bruggen, Pierre
Julkaistu 2014

MDSC in Mice and Men: Mechanisms of Immunosuppression in Cancer

Tekijä Vanhaver, Christophe, van der Bruggen, Pierre, Bruger, Annika M.
Julkaisussa J Clin Med (2021)

Immune Suppression in Tumors as a Surmountable Obstacle to Clinical Efficacy of Cancer Vaccines

Tekijä Wieërs, Grégoire, Demotte, Nathalie, Godelaine, Danièle, van der Bruggen, Pierre
Julkaistu 2011

Extracellular galectins as controllers of cytokines in hematological cancer

Tekijä Gordon-Alonso, Monica, Bruger, Annika M., van der Bruggen, Pierre
Julkaisussa Blood (2018)

Galectin-3 captures interferon-gamma in the tumor matrix reducing chemokine gradient production and T-cell tumor infiltration

Tekijä Gordon-Alonso, Monica, Hirsch, Thibault, Wildmann, Claude, van der Bruggen, Pierre
Julkaisussa Nat Commun (2017)

A CASP-8 Mutation Recognized by Cytolytic T Lymphocytes on a Human Head and Neck Carcinoma

Tekijä Mandruzzato, Susanna, Brasseur, Francis, Andry, Guy, Boon, Thierry, van der Bruggen, Pierre
Julkaistu 1997

Database of T cell-defined human tumor antigens: the 2013 update

Tekijä Vigneron, Nathalie, Stroobant, Vincent, Van den Eynde, Benoît J., van der Bruggen, Pierre
Julkaistu 2013

Loss of Effector Function of Human Cytolytic T Lymphocytes Is Accompanied by Major Alterations in N- and O-Glycosylation

Tekijä Antonopoulos, Aristotelis, Demotte, Nathalie, Stroobant, Vincent, Haslam, Stuart M., van der Bruggen, Pierre, Dell, Anne
Julkaistu 2012

Identification of MAGE-3 Epitopes Presented by HLA-DR Molecules to CD4(+) T Lymphocytes

Tekijä Chaux, Pascal, Vantomme, Valérie, Stroobant, Vincent, Thielemans, Kris, Corthals, Jurgen, Luiten, Rosalie, Eggermont, Alexander M.M., Boon, Thierry, van der Bruggen, Pierre
Julkaistu 1999

Absence of recognition of common melanocytic antigens by T cells isolated from the cerebrospinal fluid of a Vogt-Koyanagi-Harada patient

Tekijä Abad, Sébastien, Wieërs, Grégoire, Colau, Didier, Wildmann, Claude, Delair, Emmanuelle, Dhote, Robin, Brézin, Antoine P., Kawakami, Yukata, Coulie, Pierre G., van der Bruggen, Pierre
Julkaistu 2014

A major secretory defect of tumour-infiltrating T lymphocytes due to galectin impairing LFA-1-mediated synapse completion

Tekijä Petit, Anne-Elisabeth, Demotte, Nathalie, Scheid, Benoît, Wildmann, Claude, Bigirimana, René, Gordon-Alonso, Monica, Carrasco, Javier, Valitutti, Salvatore, Godelaine, Danièle, van der Bruggen, Pierre
Julkaisussa Nat Commun (2016)

CD8 T‐cell responses against the immunodominant Theileria parva peptide Tp2(49–59) are composed of two distinct populations specific for overlapping 11‐mer and 10‐mer epitopes...

Tekijä Connelley, Timothy K., Li, Xiaoying, MacHugh, Niall, Colau, Didier, Graham, Simon P., van der Bruggen, Pierre, Taracha, Evans L., Gill, Andy, Morrison, William Ivan
Julkaisussa Immunology (2016)

Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen

Tekijä Lonchay, Christophe, van der Bruggen, Pierre, Connerotte, Thierry, Hanagiri, Takeshi, Coulie, Pierre, Colau, Didier, Lucas, Sophie, Van Pel, Aline, Thielemans, Kris, van Baren, Nicolas, Boon, Thierry
Julkaistu 2004

Dendritic Cells Loaded With mRNA Encoding Full-length Tumor Antigens Prime CD4(+) and CD8(+) T Cells in Melanoma Patients

Tekijä Van Nuffel, An MT, Benteyn, Daphné, Wilgenhof, Sofie, Pierret, Lauranne, Corthals, Jurgen, Heirman, Carlo, van der Bruggen, Pierre, Coulie, Pierre G, Neyns, Bart, Thielemans, Kris, Bonehill, Aude
Julkaistu 2012

IRF1 and NF-kB Restore MHC Class I-Restricted Tumor Antigen Processing and Presentation to Cytotoxic T Cells in Aggressive Neuroblastoma

Tekijä Lorenzi, Silvia, Forloni, Matteo, Cifaldi, Loredana, Antonucci, Chiara, Citti, Arianna, Boldrini, Renata, Pezzullo, Marco, Castellano, Aurora, Russo, Vincenzo, van der Bruggen, Pierre, Giacomini, Patrizio, Locatelli, Franco, Fruci, Doriana
Julkaistu 2012

Identification of an Immature Subset of PMN-MDSC Correlated to Response to Checkpoint Inhibitor Therapy in Patients with Metastatic Melanoma

Tekijä Gondois-Rey, Françoise, Paul, Magali, Alcaraz, Florence, Bourass, Sarah, Monnier, Jilliana, Malissen, Nausicaa, Grob, Jean-Jacques, Bruger, Annika M., Van Der Bruggen, Pierre, Gaudy-Marqueste, Caroline, Olive, Daniel
Julkaisussa Cancers (Basel) (2021)

A novel strategy for the identification of antigens that are recognised by bovine MHC class I restricted cytotoxic T cells in a protozoan infection using reverse vaccinology

Tekijä Graham, Simon P, Honda, Yoshikazu, Pellé, Roger, Mwangi, Duncan M, Glew, E Jane, de Villiers, Etienne P, Shah, Trushar, Bishop, Richard, van der Bruggen, Pierre, Nene, Vishvanath, Taracha, Evans LN
Julkaistu 2007

The Production of a New MAGE-3 Peptide Presented to Cytolytic T Lymphocytes by HLA-B40 Requires the Immunoproteasome

Tekijä Schultz, Erwin S., Chapiro, Jacques, Lurquin, Christophe, Claverol, Stéphane, Burlet-Schiltz, Odile, Warnier, Guy, Russo, Vincenzo, Morel, Sandra, Lévy, Frédéric, Boon, Thierry, Van den Eynde, Benoît J., van der Bruggen, Pierre
Julkaistu 2002

Expression and prognostic relevance of MAGE-A3 and MAGE-C2 in non-small cell lung cancer

Tekijä Chen, Xinfeng, Wang, Liping, Liu, Jinyan, Huang, Lan, Yang, Li, Gao, Qun, Shi, Xiaojuan, Li, Jieyao, Li, Feng, Zhang, Zhen, Zhao, Song, Zhang, Bin, Van der Bruggen, Pierre, Zhang, Yi
Julkaisussa Oncol Lett (2017)

Exogenous loading of a tapasin-dependent peptide onto HLA-B*44:02 can be restored by acid treatment or fixation of target cells

Tekijä Stroobant, Vincent, Demotte, Nathalie, Luiten, Rosalie M., Leonhardt, Ralf M., Cresswell, Peter, Bonehill, Aude, Michaux, Alexandre, Ma, Wenbin, Mulder, Arend, Van den Eynde, Benoît J., van der Bruggen, Pierre, Vigneron, Nathalie
Julkaistu 2012